456 results on '"Straten, Per Thor"'
Search Results
52. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome
53. Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
54. Abstract B036: T-cell recognition of breast cancer antigens
55. Abstract B020: T-cell recognition of large T and small T antigen in Merkel cell polyomavirus-associated cancer
56. Collagen density regulates the activity of tumor-infiltrating T cells
57. Clonal T Cell Responses in Tumor Infiltrating Lymphocytes from both Regressive and Progressive Regions of Primary Human Malignant Melanoma
58. Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity
59. Future perspectives in melanoma research 'Melanoma Bridge', Napoli, November 30th-3rd December 2016
60. Therapy of solid cancers using T cells and running shoes
61. T cell recognition of breast cancer antigens
62. T cell recognition of large T and small T antigen in Merkel cell polyomavirus-associated cancer
63. Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
64. Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
65. Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation
66. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma
67. Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins:a phase I trial
68. Cancer immunotherapy: From the lab to clinical applications - Potential impact on cancer centres' organisation
69. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors
70. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes
71. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma
72. More tricks with tetramers:a practical guide to staining T cells with peptide-MHC multimers
73. Antibody Stabilization of Peptide–MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs
74. Broadening the repertoire of melanoma-associated T-cell epitopes
75. Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera
76. Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
77. Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.
78. Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.
79. Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes
80. Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer
81. Antibody Stabilization of Peptide–MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs
82. Spontaneous presence of FOXO3-specific T cells in cancer patients
83. Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
84. Mutational Analysis of Oncogenes and Tumor Suppressor Genes in Human Cancer Using Denaturing Gradient Gel Electrophoresis
85. Immune Risk Phenotypes and Associated Parameters in Very Old Humans: A Review of Findings in the Swedish NONA Immune Longitudinal Study
86. T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis: Analysis of Clonal T-Cell Responses in Melanoma
87. Expansion of circulating CD56brightnatural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
88. Spontaneous presence of FOXO3-specific T cells in cancer patients
89. Immune escape mechanisms associated with tumor recurrence after adoptive cell transfer immunotherapy.
90. Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase
91. BRAF inhibition improves tumor recognition by the immune system:Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
92. Immunotherapy for metastatic colorectal cancer:Present status and new options
93. A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles
94. Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures
95. Characterization and comparison of 'Standard' and 'Young' tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution
96. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
97. Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
98. HLA-A2-restricted survivin-derived T-cell responses
99. Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination
100. Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.